1. Burkitt lymphoma–multicenter retrospective data analysis from the Czech Lymphoma Study Group–NiHiL project. (June 2017) Authors: Sýkorová, A.; Pytlík, R.; Móciková, H.; Janíková, A.; Procházka, V.; Belada, D.; Šálek, D.; Benešová, K.; Klener, P.; Ďuraš, J.; Smolej, L.; Šimkovič, M.; Campr, V.; Vosáhlová, V.; Blahovcová, P.; Trněný, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOUBLE‐EXPRESSOR LYMPHOMAS DO NOT HAVE INFERIOR OUTCOME AFTER AUTOLOGOUS STEM‐CELL TRANSPLANT IN THE FIRST LINE TREATMENT. (June 2017) Authors: Trneny, M.; Campr, V.; Pytlik, R.; Klener, P.; Stritesky, J.; Jaksa, R.; Boudova, L.; Benesova, K.; Koren, J.; Trnkova, M.; Blahovcova, P.; Klanova, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ESTABLISHED CELL LINES AND PATIENT‐DERIVED XENOGRAFTS REPRESENT EQUALLY RELEVANT MODELS OF AGGRESSIVE LYMPHOMAS. (June 2017) Authors: Klener, P.; Klánová, M.; Molinský, J.; Svatoň, M.; Berková, A.; Zemanová, Z.; Jakša, R.; Špaček, M.; Březinová, J.; Tichá, I.; Jančušková, T.; Hardekopf, D.W.; Forsterová, K.; Froňková, E.; Kotrová, M.; Kubričanová‐Žaliová, M.; Maswabi, B.C.; Průková, D.; Vočková, P.; Tušková, D. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EXTRANODAL NATURAL KILLER (NK)/T‐CELL LYMPHOMA, NASAL TYPE – CASE REPORT AND REVIEW OF CZECH LYMPHOMA STUDY GROUP (CLSG) DATABASE. (12th June 2019) Authors: Steinerova, K.; Jindra, P.; Lysak, D.; Karas, M.; Trneny, M.; Klener, P.; Sykorova, A.; Belada, D.; Janikova, A.; Pytlik, R.; Prochazka, V.; Benesova, K.; Blahovcova, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MAINTENANCE RITUXIMAB IMPROVES SURVIVAL IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA PATIENTS: ANALYSIS OF THE CZECH LYMPHOMA STUDY GROUP. (June 2017) Authors: Obr, A.; Klener, P.; Belada, D.; Pytlik, R.; Simkovic, M.; Salek, D.; Mocikova, H.; Prochazka, V.; Janikova, A.; Markova, J.; Campr, V.; Kodet, R.; Trneny, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Optimized Multiplex IgH/ras PCR: A Tool for Quantitative Monitoring of B-Lymphoproliferative Disorders. (April 2000) Authors: Slavíčková, Alena; Ullmannová, V.; Klener, P. Journal: Biotechniques Issue: Volume 28:Number 4(2000) Page Start: 716 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PROGNOSTIC VALUE OF THE INTERVAL BETWEEN RELAPSE AND THERAPY INITIATION IN DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS. ANALYSIS FROM THE CZECH LYMPHOMA STUDY GROUP DATABASE. (12th June 2019) Authors: Janikova, A.; Chloupkova, R.; Campr, V.; Kopalova, N.; Klener, P.; Benesova, K.; Hamouzova, J.; Belada, D.; Sykorova, A.; Prochazka, V.; Pirnos, J.; Duras, J.; Mocikova, H.; Michalka, J.; Trneny, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. RITUXIMAB MAINTENANCE AFTER NORDIC PROTOCOL (R‐MAXICHOP/HD‐ARAC/ASCT) SIGNIFICANTLY PROLONGS SURVIVAL IN YOUNG MANTLE CELL LYMPHOMA PATIENTS. (June 2017) Authors: Klener, P.; Salek, D.; Mocikova, H.; Blahovcova, P.; Pytlik, R.; Janikova, A.; Prochazka, V.; Campr, V.; Boudova, L.; Jaksa, R.; Kodet, R.; Trneny, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. R‐CHOP/R‐HDAC AND RITUXIMAB MAINTENANCE RESULTS IN HIGH COMPLETE REMISSION RATE, MINIMAL RESIDUAL DISEASE NEGATIVITY, AND EXCELLENT SURVIVAL IN ELDERLY MCL PATIENTS. (June 2017) Authors: Klener, P.; Fronkova, E.; Belada, D.; Forsterova, K.; Pytlik, R.; Kalinova, M.; Simkovic, M.; Salek, D.; Mocikova, H.; Prochazka, V.; Blahovcová, P.; Janikova, A.; Markova, J.; Obr, A.; Berkova, A.; Vaskova, M.; Mejstrikova, E.; Campr, V.; Kubinyi, J.; Jaksa, R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S154: IMATINIB-RESISTANT CLONES ISOLATED FROM A MODEL OF BLAST CRISIS OF CHRONIC MYELOID LEUKAEMIA DIFFER IN MUTATIONS IN BCR:ABL1 AND OTHER CANCER RELATED GENES AND IN THEIR SENSITIVITY TO BH3-MIMETICS. (23rd June 2022) Authors: Laznicka, A.; Curik, N.; Polivkova, V.; Koblihova, J.; Burda, P.; Dolnikova, A.; Pokorna, E.; Salek, C.; Klamova, H.; Srbova, D.; Klener, P.; Machova Polakova, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗